Extending treatment after liver transplant may benefit patients with hepatitis C recurrence

		IMAGE: This is Kimberly Brown, M.D., Division head of Gastroenterology at Henry Ford Hospital and senior author of the study. Click here for more information.

DETROIT – Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.